Clearing the Air: Identifying and Addressing Lung Cancer Disparities in Philadelphia
A Rare Collaboration Among Health Systems Raises Hopes of More Screening and Better Care
News
Penn LDI’s Alison Buttenheim and Kevin Volpp Named to New NASEM Committee
Thirteen-Member Group Eyes Future Research and Broader Policy Applications of Behavioral Economics
Print:
The University of Pennsylvania’s Alison Buttenheim, PhD, MBA, and Kevin Volpp, MD, PhD, have been named members of a new National Academies of Sciences, Engineering, and Medicine (NASEM) committee that will assess future prospects for the broader use of behavioral economics in public policy.
Beginning this week, the two LDI Senior Fellows will join 11 other academics in reviewing the evidence of how behavioral economics principles have successfully or unsuccessfully been applied in various fields over the last decade. The goal is to identify insights that can help direct future research related to public health, chronic illness, economic well-being, and global climate change.
The new “Future Directions for Applying Behavioral Economics to Policy” committee will be co-chaired by Buttenheim and Robert Moffitt, PhD, of the John Hopkins University Department of Economics.
“Given ongoing policy interest in applying behavioral economics to pressing social problems, this consensus committee is launching at the perfect moment,” said Buttenheim. “I’m excited to be co-chairing the committee as a social scientist trained in public health – the interdisciplinary perspective on these important issues will be critical.”
Buttenheim is the Director of Engagement at Penn LDI, an Associate Professor of Nursing at Penn’s School of Nursing, Scientific Director of the Penn Center for Health Incentives and Behavioral Economics (CHIBE), and the behavioral design lead for Indlela, an HIV-focused nudge unit based in South Africa.
“There have been a lot of demonstrations of how interventions based on concepts from behavioral economics can be effective,” said Volpp. “In some cases, these programs have been scaled by a variety of organizations. This is a good time to take stock of progress — where new scientific advances are needed and where a systematic look at what has been scaled and what hasn’t could lead to improvements in health or health care.”
Volpp is a Professor at the Perelman School of Medicine and at The Wharton School, and is the Director of the Penn Center for Health Incentives and Behavioral Economics (CHIBE). CHIBE is one of the country’s leading centers for behavioral economics research.
More LDI News
Will Over-the-Counter Access Increase Availability of an Overdose-Reverser and an Oral Contraceptive?
Probably Not: If the Past Is Any Guide, Cost and Access Will Likely Stand in the Way
Americans May Support Medicaid Work Requirements But Not Efforts to Exclude People for Noncompliance
Survey Shows Surprising Agreement Among Groups Regarding Health Care Coverage Policies
Fentanyl Remains the Big Driver of Overdoses so Stay Focused on Naloxone as an Antidote
LDI’s Jeanmarie Perrone Names Biggest Takeaways from NIDA’s Conference on Opioid Care
The Epidemic of Black Women Overdoses
Deaths Have Soared Since 2015, and Younger Black Women Are at Special Risk
The Expansion of Medicare Advantage and Solvency of Traditional Medicare
Penn LDI Virtual Seminar Focuses Top Experts on a Formidable Tangle of Policy Issues